Q4 EPS Forecast for Encompass Health Decreased by Analyst

Encompass Health Co. (NYSE:EHC) – Equities research analysts at Zacks Research reduced their Q4 2025 earnings per share estimates for shares of Encompass Health in a report issued on Wednesday, January 8th. Zacks Research analyst Z. Masood now expects that the company will post earnings of $1.14 per share for the quarter, down from their prior estimate of $1.15. The consensus estimate for Encompass Health’s current full-year earnings is $4.29 per share. Zacks Research also issued estimates for Encompass Health’s Q2 2026 earnings at $1.40 EPS.

EHC has been the topic of a number of other research reports. UBS Group upped their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Truist Financial reiterated a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp boosted their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Royal Bank of Canada raised their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Finally, Barclays boosted their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Performance

Encompass Health stock opened at $91.08 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a market capitalization of $9.18 billion, a P/E ratio of 22.00, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. Encompass Health has a 1-year low of $67.94 and a 1-year high of $104.55. The company’s 50-day moving average is $98.23 and its 200 day moving average is $93.65.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same period in the previous year, the firm earned $0.86 earnings per share. Encompass Health’s quarterly revenue was up 11.9% compared to the same quarter last year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.75%. Encompass Health’s dividend payout ratio is presently 16.43%.

Hedge Funds Weigh In On Encompass Health

A number of large investors have recently bought and sold shares of the business. UMB Bank n.a. increased its holdings in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after acquiring an additional 252 shares during the period. V Square Quantitative Management LLC boosted its position in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC purchased a new position in Encompass Health in the third quarter valued at about $40,000. Benjamin F. Edwards & Company Inc. raised its holdings in Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after purchasing an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Encompass Health during the second quarter valued at about $58,000. Institutional investors own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.